{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:15:40Z","timestamp":1793294140195,"version":"4.5.0"},"reference-count":103,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,6,29]],"date-time":"2007-06-29T00:00:00Z","timestamp":1183075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2007,8]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Venous thrombosis is more frequent in patients treated for acute lymphoblastic leukaemia (ALL) than other malignancies and has distinctive causes, clinical features and remedies. The reported incidence varies from 1% to 36%, depending on the chemotherapy protocol and whether the reported cases are symptomatic or detected on screening radiography. The risk is thought to arise from increased thrombin generation at diagnosis combined with reduced thrombin inhibitory capacity due to depletion of circulating anti\u2010thrombin (AT) by asparaginase. A number of patient and treatment variables have been reported to influence the risk of thrombosis including hereditary thrombophilia, early insertion of central venous catheters and exposure to a combination of steroids and asparaginase during induction. Erwinia asparaginase is associated with a lower risk of thrombosis compared with <jats:italic>Escherichia coli<\/jats:italic> asparaginase. The majority of symptomatic thromboses are related to central venous catheters and involve the upper venous system. Central nervous system thrombosis involving the cerebral venous sinuses is a unique feature of asparaginase\u2010related thrombosis and is reported to occur in 1\u20133% of patients. Conclusive evidence to support the use of anti\u2010coagulant treatment or AT concentrates for primary prevention is lacking, as is evidence for the efficacy of AT concentrates in the management of established thrombosis. Preventative strategies are hampered by conflicting data on factors that would enable identification of those at highest risk of thrombosis.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2007.06677.x","type":"journal-article","created":{"date-parts":[[2007,6,30]],"date-time":"2007-06-30T03:49:00Z","timestamp":1183175340000},"page":"430-445","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":142,"title":["Thrombosis and acute lymphoblastic leukaemia"],"prefix":"10.1111","volume":"138","author":[{"given":"Jeanette H.","family":"Payne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay J.","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03148.x"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.5.1251.1251"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000214709.11492.ec"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2003.10.013"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2003.10.007"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05528.x"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05953.x"},{"key":"e_1_2_9_9_1","first-page":"963","article-title":"Continuous infusion of low\u2010dose urokinase in the treatment of central venous catheter thrombosis in infants and children","volume":"83","author":"Bagnall H.A.","year":"1989","journal-title":"Pediatrics"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-76-3-112-6-423"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(86)81044-7"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.401S"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(00)00017-5"},{"key":"e_1_2_9_14_1","first-page":"335","article-title":"Adverse reactions of L\u2010asparaginase","volume":"4","author":"Cairo M.S.","year":"1982","journal-title":"American Journal of Pediatric Hematology\/Oncology"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-74-6-893"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1995.tb00699.x"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015511"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02383.x"},{"key":"e_1_2_9_19_1","first-page":"57","article-title":"Erwinia\u2010 and E. coli\u2010derived L\u2010asparaginase have similar effects on hemostasis. Pilot study in 10 patients with acute lymphoblastic leukemia","volume":"78","author":"Castaman G.","year":"1993","journal-title":"Haematologica"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003693.pub2"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770050324"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.10.192"},{"key":"e_1_2_9_23_1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1055\/s-0038-1657142","article-title":"Increased factor VIII associated activities in Cushing's syndrome: a probable hypercoagulable state","volume":"47","author":"Dal Bo Zanon R.","year":"1982","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.8.2734"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200107000-00005"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190410001693588"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.338S"},{"key":"e_1_2_9_28_1","first-page":"29","volume-title":"Royal College of Paediatrics and Child Health, British Paediatric Surveillance Unit 17th Annual Report 2002\u20133","author":"Gibson B.E.","year":"2003"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1080\/08880010050211376"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.111272"},{"key":"e_1_2_9_31_1","first-page":"V88","article-title":"The THROMBOTECT trial\u2010 the first randomised multicenter interventional study on prevention of thromboembolism in induction chemotherapy for childhood acute lymphoblastic leukemia","volume":"24","author":"Greiner J.","year":"2004","journal-title":"Hamostaseologie"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb06336.x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1992.tb00032.x"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19901201)66:11<2279::AID-CNCR2820661105>3.0.CO;2-O"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1648911"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.2830470302"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.188S"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1442-200X.2002.01556.x"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/030089160409000405"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1970.tb01890.x"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70338-4"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1046625"},{"key":"e_1_2_9_43_1","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1182\/blood.V108.11.1497.1497","article-title":"Incidence of venous thromboembolism in patients with acute leukemia","volume":"108","author":"Ku G.","year":"2006","journal-title":"Blood"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2003.09.008"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06209.x"},{"key":"e_1_2_9_46_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-0038-1651179","article-title":"Evidence Of a hypercoagulable state in patients with acute lymphoblastic leukemia treated with low dose of E. coli L\u2010asparaginase: a GIMEMA study","volume":"69","author":"Leone G.","year":"1993","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613054"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2731"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(98)70149-0"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(03)00099-9"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(03)00059-8"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1043791"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1613930"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.12.097"},{"key":"e_1_2_9_55_1","first-page":"116","article-title":"Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L\u2010asparaginase schedules","volume":"8","author":"Miniero R.","year":"1986","journal-title":"American Journal of Pediatric Hematology\/Oncology"},{"key":"e_1_2_9_56_1","first-page":"67","article-title":"Low\u2010molecular\u2010weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long\u2010term central venous catheters: a pilot randomized trial","volume":"88","author":"Mismetti P.","year":"2003","journal-title":"Haematologica"},{"key":"e_1_2_9_57_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.386.386"},{"key":"e_1_2_9_58_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1000660"},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11042"},{"key":"e_1_2_9_60_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1160\/TH02-11-0283","article-title":"Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l\u2010asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study","volume":"90","author":"Mitchell L.","year":"2003","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05509.x"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.3_suppl.645S"},{"key":"e_1_2_9_63_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-0038-1650254","article-title":"Upper extremity deep venous thrombosis in cancer patients with venous access devices \u2013prophylaxis with a low molecular weight heparin (Fragmin)","volume":"75","author":"Monreal M.","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1040-8428(98)00015-8"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880019609030829"},{"key":"e_1_2_9_66_1","first-page":"451","article-title":"Inefficacy of fresh frozen plasma in the treatment of L\u2010asparaginase\u2010induced coagulation factor deficiencies during ALL induction therapy","volume":"80","author":"Nowak\u2010Gottl U.","year":"1995","journal-title":"Haematologica"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1873.x"},{"key":"e_1_2_9_68_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.424957.x"},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1996.tb00290.x"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004310050727"},{"key":"e_1_2_9_71_1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood.V93.5.1595","article-title":"Prospective evaluation of the thrombotic risk in children with acute lymphoblastic leukemia carrying the MTHFR TT 677 genotype, the prothrombin G20210A variant, and further prothrombotic risk factors","volume":"93","author":"Nowak\u2010Gottl U.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(01)00286-9"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-06-1901"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04972.x"},{"key":"e_1_2_9_75_1","doi-asserted-by":"crossref","first-page":"258a","DOI":"10.1182\/blood.V106.11.878.878","article-title":"Treatment outcome of discontinued L\u2010asaparginase in children with standard\u2010risk acute lymphoblastic leukemia: Tokoyo Children's Cancer Study Group (TCCSG) Study L99\u201015","volume":"106","author":"Ogawa C.","year":"2005","journal-title":"Blood"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2001.118192"},{"key":"e_1_2_9_77_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199909058436"},{"key":"e_1_2_9_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/1951214a0"},{"key":"e_1_2_9_79_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199505270-00010"},{"key":"e_1_2_9_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1051-0443(07)61575-9"},{"key":"e_1_2_9_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(82)80536-2"},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.9.1266"},{"key":"e_1_2_9_83_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb04121.x"},{"key":"e_1_2_9_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/0730-4862(87)90014-X"},{"key":"e_1_2_9_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197710)40:4<1398::AID-CNCR2820400406>3.0.CO;2-#"},{"key":"e_1_2_9_86_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1538-7836.2003.00158.x"},{"key":"e_1_2_9_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(01)00285-7"},{"key":"e_1_2_9_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(90)90193-G"},{"key":"e_1_2_9_89_1","doi-asserted-by":"publisher","DOI":"10.1080\/08035250600729092"},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000157379.44167.b5"},{"key":"e_1_2_9_91_1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-0038-1647150","article-title":"Unbalanced coagulation\u2010fibrinolysis potential during L\u2010asparaginase therapy in children with acute lymphoblastic leukaemia","volume":"64","author":"Semeraro N.","year":"1990","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_9_92_1","first-page":"400","article-title":"Thrombosis in children receiving L\u2010asparaginase. Determining patients at risk","volume":"15","author":"Shapiro A.D.","year":"1993","journal-title":"American Journal of Pediatric Hematology\/Oncology"},{"key":"e_1_2_9_93_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.5.1211"},{"key":"e_1_2_9_94_1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002005"},{"key":"e_1_2_9_95_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10263"},{"key":"e_1_2_9_96_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1043788"},{"key":"e_1_2_9_97_1","first-page":"A211","article-title":"von Willebrand factor in children with acute lymphoblastic leukemia(ALL) treated according to ALL\u2010BFM\u201090 protocol. Preliminary results","volume":"69","author":"Thomas K.B.","year":"1993","journal-title":"Thrombosis and Haemostasis"},{"key":"e_1_2_9_98_1","doi-asserted-by":"publisher","DOI":"10.1159\/000186178"},{"key":"e_1_2_9_99_1","first-page":"108","article-title":"Children with acute lymphoblastic leukemia: is there any subgroup of children without elevated thrombin generation? A preliminary study utilizing measurements of thrombin\u2010antithrombin III complexes","volume":"6","author":"Uszynski M.","year":"2000","journal-title":"Medical Science Monitor"},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.06.084"},{"key":"e_1_2_9_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(90)90122-S"},{"key":"e_1_2_9_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00014341"},{"key":"e_1_2_9_103_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1043790"},{"key":"e_1_2_9_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.07.016"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2007.06677.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2007.06677.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:37:24Z","timestamp":1697423844000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2007.06677.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,29]]},"references-count":103,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["10.1111\/j.1365-2141.2007.06677.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2007.06677.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,29]]},"assertion":[{"value":"2007-06-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}